Safe And Cure Superspecialities Hospital Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 5.00 M
as on 16-11-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.13 Cr
as on 16-11-2024
- Revenue 48.98%
(FY 2023)
- Profit -71.27%
(FY 2023)
- Ebitda -24.44%
(FY 2023)
- Net Worth 125.56%
(FY 2023)
- Total Assets 35.41%
(FY 2023)
About Safe And Cure Superspecialities Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.13 Cr.
Radha Kaler, Vivek Kaler, Hardeo Kaler, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999RJ2018PTC061784
- Company No.
061784
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Sikar, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Safe And Cure Superspecialities Hospital?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Radha Kaler  | Director | 12-Jul-2018 | Current |
| Vivek Kaler | Director | 12-Jul-2018 | Current |
| Hardeo Kaler | Director | 12-Jul-2018 | Current |
| Sucheta Kaler | Director | 12-Jul-2018 | Current |
Financial Performance of Safe And Cure Superspecialities Hospital.
Safe And Cure Superspecialities Hospital Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.98% increase. The company also saw a substantial fall in profitability, with a 71.27% decrease in profit. The company's net worth Soared by an impressive increase of 125.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Safe And Cure Superspecialities Hospital?
In 2023, Safe And Cure Superspecialities Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Deevee Marbles Private LimitedActive 30 years 7 monthsRadha Kaler, Vivek Kaler and 2 more are mutual person
- Tenfold Pharmaceuticals Private LimitedActive 19 years 3 months
Radha Kaler and Vivek Kaler are mutual person
- Frontline Infratech Private LimitedActive 13 years 11 months
Radha Kaler, Vivek Kaler and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 May 2023 | ₹1.13 Cr | Open |
How Many Employees Work at Safe And Cure Superspecialities Hospital?
Unlock and access historical data on people associated with Safe And Cure Superspecialities Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Safe And Cure Superspecialities Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Safe And Cure Superspecialities Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
